22 Oct 2022 , 08:03 AM
Net profit of Eiko Lifesciences declined 31.82% to Rs 0.15 crore in the quarter ended September 2022 as against Rs 0.22 crore during the previous quarter ended September 2021. Sales declined 29.23% to Rs 4.31 crore in the quarter ended September 2022 as against Rs 6.09 crore during the previous quarter ended September 2021.
Particulars | Quarter Ended | ||
? | Sep. 2022 | Sep. 2021 | % Var. |
Sales | 4.31 | 6.09 | -29 |
OPM % | 3.25 | 7.39 | – |
PBDT | 0.36 | 0.45 | -20 |
PBT | 0.20 | 0.29 | -31 |
NP | 0.15 | 0.22 | -32 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.